PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
-13.7%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$9.35B
AUM Growth
-$2.4B
(-20%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
23.17%
Holding
296
New
31
Increased
109
Reduced
93
Closed
43
Top Buys
| 1 |
Danaher
DHR
|
$66.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$61M |
| 3 |
Thermo Fisher Scientific
TMO
|
$51.3M |
| 4 |
Boston Scientific
BSX
|
$44.2M |
| 5 |
Arista Networks
ANET
|
$43.1M |
Top Sells
| 1 |
Merck
MRK
|
$115M |
| 2 |
Amgen
AMGN
|
$102M |
| 3 |
Apple
AAPL
|
$82.8M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$72.8M |
| 5 |
Flex
FLEX
|
$70.4M |
Sector Composition
| 1 | Technology | 25.49% |
| 2 | Financials | 23.49% |
| 3 | Healthcare | 21.31% |
| 4 | Communication Services | 7.67% |
| 5 | Consumer Discretionary | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Wolfspeed
WOLF
$194M
| $13.2M | 0.14% |
308,607
+32,860
| +12% | +$1.41M |
|
152
BioMarin Pharmaceuticals
BMRN
$11.1B
| $13.1M | 0.14% |
154,370
| – | – |
|
153
PNC Financial Services
PNC
$80.5B
| $12.9M | 0.14% |
110,545
-729
| -0.7% | -$85.2K |
|
154
Grifois
GRFS
$6.86B
| $12.9M | 0.14% |
703,370
| – | – |
|
|
IMMU
155
DELISTED
Immunomedics Inc
IMMU
| $12.9M | 0.14% |
+904,416
| New | +$12.9M |
|
156
ResMed
RMD
$40.6B
| $12.5M | 0.13% |
+110,000
| New | +$12.5M |
|
157
Quest Diagnostics
DGX
$20.4B
| $12.4M | 0.13% |
149,254
| – | – |
|
|
ZGNX
158
DELISTED
Zogenix, Inc.
ZGNX
| $12.2M | 0.13% |
334,569
-116,733
| -26% | -$4.26M |
|
|
AZPN
159
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $11.8M | 0.13% |
143,306
+17,357
| +14% | +$1.43M |
|
|
SIEN
160
DELISTED
Sientra, Inc.
SIEN
| $11.5M | 0.12% |
90,390
-9,610
| -10% | -$1.22M |
|
161
Becton Dickinson
BDX
$55B
| $11.3M | 0.12% |
51,277
| – | – |
|
162
Ares Capital
ARCC
$15.8B
| $11.2M | 0.12% |
721,732
-10,000
| -1% | -$156K |
|
163
First American
FAF
$6.8B
| $11.2M | 0.12% |
+250,000
| New | +$11.2M |
|
164
Jazz Pharmaceuticals
JAZZ
$7.88B
| $11.1M | 0.12% |
89,500
-70,000
| -44% | -$8.68M |
|
165
UBS Group
UBS
$128B
| $10.9M | 0.12% |
849,839
-8,891
| -1% | -$114K |
|
|
MYOK
166
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.2M | 0.11% |
208,193
+116,907
| +128% | +$5.71M |
|
167
Align Technology
ALGN
$9.98B
| $10.2M | 0.11% |
48,554
-66,077
| -58% | -$13.8M |
|
168
SLR Investment Corp
SLRC
$910M
| $9.66M | 0.1% |
503,278
| – | – |
|
169
PennantPark Floating Rate Capital
PFLT
$1.01B
| $9.53M | 0.1% |
824,000
+37,315
| +5% | +$432K |
|
170
Inogen
INGN
$221M
| $9.48M | 0.1% |
+76,379
| New | +$9.48M |
|
171
Keysight
KEYS
$28.8B
| $9.16M | 0.1% |
147,591
-252,653
| -63% | -$15.7M |
|
172
Aptiv
APTV
$17.4B
| $9.08M | 0.1% |
+147,507
| New | +$9.08M |
|
|
NSTG
173
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.9M | 0.1% |
600,000
+100,000
| +20% | +$1.48M |
|
|
FRC
174
DELISTED
First Republic Bank
FRC
| $8.67M | 0.09% |
99,776
-22,877
| -19% | -$1.99M |
|
175
Madrigal Pharmaceuticals
MDGL
$9.72B
| $8.45M | 0.09% |
+75,000
| New | +$8.45M |
|